Ocera Therapeutics (OCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 31 | 30 | 233 | 33 | 45 |
| Gross Profit | 31 | 30 | 233 | 33 | 45 |
| Operating Expenses | 6,695 | 5,579 | 6,912 | 7,288 | 5,240 |
| Operating Income | -6,664 | -5,549 | -6,679 | -7,255 | -5,195 |
| Interest Expense | 14 | 0 | 0 | 0 | 0 |
| Other Income | 27 | 11 | 18 | 12 | 13 |
| Pre-tax Income | -6,651 | -5,538 | -6,661 | -7,243 | -5,182 |
| Net Income Continuous | -6,651 | -5,538 | -6,661 | -7,243 | -5,182 |
| Net Income Discontinuous | N/A | 4 | 58 | 20 | 1,117 |
| Net Income | $-6,651 | $-5,534 | $-6,603 | $-7,223 | $-4,065 |
| EPS Basic Total Ops | -0.34 | -0.27 | -0.34 | -0.46 | -0.27 |
| EPS Basic Continuous Ops | -0.34 | -0.27 | -0.34 | -0.46 | -0.34 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 0.00 | 0.00 | 0.07 |
| EPS Diluted Total Ops | -0.34 | -0.27 | -0.34 | -0.46 | -0.27 |
| EPS Diluted Continuous Ops | -0.34 | -0.27 | -0.34 | -0.46 | -0.34 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 0.00 | 0.00 | 0.07 |
| EBITDA(a) | $-6,461 | $-5,309 | $-6,221 | $-7,299 | $-5,049 |